The infusion pumps market is expected to reach USD 20.5 Billion by 2026 from an estimated USD 13.2 Billion in 2021, at a CAGR of 9.3%. The increasing incidence of chronic diseases along with the rapid growth of the geriatric population, rising demand for …
Medical Equipment Global Market Opportunities And Strategies To 2032Including: 1) By Type: In-Vitro Diagnostics; Dental Equipment And Supplies; Ophthalmic Devices; Diagnostic Imaging Equipment; Cardiovascular Devices; Hospital Supplies; Surgical Equipment; Orthopedic Devices; Patient Monitoring Devices; Diabetes Care Devices; Nephrology And Urology Devices; ENT Devices; Anesthesia And Respiratory Devices; Neurology Devices; Wound Care Devices.2) By Type Of Expenditure: Public; Private3) By Product: Instruments And Equipment; Disposables And Consumables4) By End User: Hospitals And Clinics; Homecare And Diagnostic CentersCovering: Medtronic Inc; Abbott Laboratories; Johnson & Johnson; Siemens AG; Becton Dickinson and Company(BD)
この調査レポートは、COVID 19の閉鎖から立ち上がる世界の医療機器市場を評価するために必要な重要情報を提供します。
Reasons to Purchase
・ Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies…
Chronic Cough (Respiratory) - Drugs in Development, 2021SummaryChronic Cough (Respiratory) - Drugs in Development, 2021 provides an overview of the Chronic Cough pipeline landscape.The report provides comprehensive information on the therapeutics under de…
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Drugs in Development, 2021
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Drugs in Development, 2021SummaryAtypical Chemokine R…
Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021SummaryPulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Fibrosis pipeline landscape.The report provides comprehensive information on the therap…
Emphysema (Respiratory) - Drugs in Development, 2021SummaryEmphysema (Respiratory) - Drugs in Development, 2021 provides an overview of the Emphysema pipeline landscape.The report provides comprehensive information on the therapeutics under development fo…
Sepsis (Infectious Disease) - Drugs in Development, 2021SummarySepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Sepsis pipeline landscape.The report provides comprehensive information on the therapeutics under developme…